In BMC Cancer this week, researchers in Germany report their study of the associations between human chorionic gonadotropin and grade, stage, and patient survival in ovarian cancer. The team gathered data from patients diagnosed and treated for ovarian tumors, and measured their serum hCG concentration.
This Week in BMC Cancer
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.